ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

AXSM Axsome Therapeutics Inc

75,385
0,585 (0,78%)
Última atualização: 12:27:31
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Axsome Therapeutics Inc AXSM NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,585 0,78% 75,385 12:27:31
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
75,00 73,31 77,98 74,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/05/202409:09IHMARKETNEWSIndex Futures Point to Strong Monday Opening, Building on..
06/05/202408:00GLOBEAxsome Therapeutics Reports First Quarter 2024 Financial..
01/05/202408:00GLOBEAxsome Therapeutics Recognizes May as Mental Health..
15/04/202408:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
10/04/202408:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
01/04/202408:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
25/03/202408:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
25/03/202407:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
19/03/202408:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
05/03/202409:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
27/02/202409:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
20/02/202409:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
20/02/202407:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
23/01/202409:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
04/01/202409:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
11/12/202309:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
07/12/202309:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
22/11/202309:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
21/11/202309:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
06/11/202309:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
06/11/202308:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
02/11/202308:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
31/10/202308:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
24/10/202308:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
11/10/202308:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10/10/202308:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
02/10/202308:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
21/09/202308:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
07/09/202308:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
05/09/202308:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
07/08/202308:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
12/07/202308:00GLOBEAxsome Therapeutics to Report Second Quarter 2023 Financial..
07/07/202308:00GLOBEAxsome Therapeutics Initiates FOCUS Phase 3 Trial of..
30/06/202317:02GLOBEAxsome Therapeutics Announces Closing of Public Offering of..
28/06/202310:28GLOBEAxsome Therapeutics Announces Pricing of Public Offering of..
27/06/202321:24GLOBEAxsome Therapeutics Announces Proposed Public Offering of..
01/06/202308:00GLOBEAxsome Therapeutics to Present New Sunosi® Data at SLEEP..
30/05/202308:00GLOBEAxsome Therapeutics to Present Data and Post-Hoc Analyses on..
08/05/202308:00GLOBEAxsome Therapeutics Reports First Quarter 2023 Financial..

Seu Histórico Recente

Delayed Upgrade Clock